Home › Therapeutic areas › Infectious Disease › Hepatitis B

Hepatitis B (5 companies)

Companies with an active program in Hepatitis B.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ADMA Adma Biologics ImmunologyInfectious Disease Rare 1 Approved $3.02B 4
ENTA Enanta Pharmaceuticals DermatologyImmunology+2 1 Approved $253M 8
IMCR Immunocore DermatologyInfectious Disease+2 1 Approved $1.44B 12
IONS Ionis Pharmaceuticals CardiovascularHematology+5 Rare 1 Approved $4.49B 29
DTIL Precision Biosciences Infectious DiseaseMetabolic+1 Rare 1 Phase 1 $197M 5